The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCarclo Regulatory News (CAR)

Share Price Information for Carclo (CAR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.50
Bid: 13.00
Ask: 15.00
Change: 0.00 (0.00%)
Spread: 2.00 (15.385%)
Open: 14.50
High: 14.50
Low: 14.50
Prev. Close: 14.00
CAR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Trading Update

2 Sep 2021 07:00

RNS Number : 4620K
Carclo plc
02 September 2021
 

 

2 September 2021

 

Carclo plc

 

("Carclo" or the "Group")

 

AGM Trading Update

 

 

Carclo, a global manufacturer, principally of fine tolerance injection moulded plastic parts, publishes the following trading update for the first four months of its financial year ending 31 March 2022 ("FY22"), ahead of its Annual General Meeting which takes place today.

 

The Group has made an encouraging start to FY22, maintaining the momentum built in the second half of the prior year in spite of a challenging operating environment. As a result, Group trading was ahead of management's expectations for the first four months of FY22, with performance also ahead of the equivalent prior period.

 

The Carclo Technical Plastics (CTP) division has performed strongly despite operational headwinds. Specifically, labour availability in the division's US businesses has been challenging in the early part of FY22, although this is expected to improve in the coming months as government support packages come to an end. The availability and pricing of raw materials has also been difficult in recent months as general supply and logistics issues impact the business. Some of the resultant input cost inflation has been offset by sales price increases. Inventories have also been held at a higher level to protect against supply disruption.

 

Alongside the positive trading performance, the division continues to make good commercial progress with order intake in the medical and diagnostic sector remaining strong and showing some good potential.

 

The new customer programmes announced in December 2020 are moving into production on time and to budget, with these providing significant growth potential from the latter part of FY22.

 

The Aerospace division has experienced early signs of market recovery with order intake exceeding sales for the first four months of FY22 following a FY21 where sales exceeded order intake. In addition to a general market improvement, the division has been successful in winning business with new customers in line with its long-term strategy.

 

Cash generation has also continued to be good in the first four months of FY22 and ahead of the prior year, with net debt as at 31 July 2021 of £28.4m and net debt excluding lease liabilities of £21.8m. At a Group level the positive developments previously reported relating to the relationships with our principal bank and pension trustees have been maintained and further initiatives are being developed with the pension trustees to aim to improve the pension scheme's funding level more quickly than would be the case by employer contributions alone.

Carclo plans to announce its interim results for the six months to 30 September 2021 in November 2021.

About Carclo plc

Carclo plc is a public company whose shares are quoted on the Main Market of the London Stock Exchange. The Group is a global provider of value-adding engineered solutions for the medical, optical and aerospace industries.

 

 

LEI: 21380078MEM399JPI956

 

Enquiries:

Carclo plc 01924 268040

Nick Sanders - Executive Chairman

 

FTI Consulting 020 3727 1340

Nick Hasell / Susanne Yule

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTUPUWGBUPGGMG
Date   Source Headline
26th Mar 201912:02 pmRNSPrice Monitoring Extension
26th Feb 20197:00 amRNSHolding(s) in Company
22nd Feb 201910:52 amRNSHolding(s) in Company
19th Feb 20199:39 amRNSAppointment of Chief Operating Officer
19th Feb 20199:16 amRNSHolding(s) in Company
7th Feb 20193:32 pmRNSHolding(s) in Company
6th Feb 20195:57 pmRNSHolding(s) in Company
6th Feb 20191:57 pmRNSHolding(s) in Company
6th Feb 20191:56 pmRNSHolding(s) in Company
6th Feb 201911:51 amRNSHolding(s) in Company
6th Feb 201911:51 amRNSDirector/PDMR Shareholding
31st Jan 201911:12 amRNSHolding(s) in Company
16th Jan 201912:37 pmRNSHolding(s) in Company
16th Jan 201911:43 amRNSHolding(s) in Company
11th Jan 20197:00 amRNSTrading Statement
21st Nov 20182:49 pmRNSHolding(s) in Company
13th Nov 20187:00 amRNSHalf-year Report
12th Oct 20187:00 amRNSTrading Update
29th Aug 20185:08 pmRNSHolding(s) in Company
13th Aug 201811:39 amRNSDirector/PDMR Shareholding
9th Aug 20188:08 amRNSForm 8.3 - [Carclo plc]
9th Aug 20187:24 amRNSForm 8.5 (EPT/RI) Consort Medical Plc
9th Aug 20187:20 amRNSForm 8.5 (EPT/RI) - Carclo Plc
8th Aug 20188:46 amRNSForm 8.3 - [Carclo plc]
7th Aug 20181:46 pmRNSHolding(s) in Company
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
7th Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
7th Aug 201810:36 amRNSForm 8.3 - [Carclo plc]
7th Aug 20189:43 amRNSStatement re withdrawal of Consort Medical plc
7th Aug 20188:23 amRNSConsort Medical No Intention to Bid for Carclo plc
3rd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
3rd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
2nd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
2nd Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
1st Aug 20182:52 pmRNSDirector/PDMR Shareholding
1st Aug 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
1st Aug 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
1st Aug 20189:47 amRNSForm 8 (DD) - Carclo
1st Aug 20189:41 amRNSForm 8 (DD) - Carclo
1st Aug 20189:38 amRNSPerformance Share Plan
1st Aug 20188:19 amRNSForm 8.3 - [Carclo plc]
31st Jul 201812:00 pmRNSForm 8.5 (EPT/RI) Consort Medical Plc
31st Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
31st Jul 201811:01 amRNSForm 8 (DD) - Carclo
31st Jul 201810:54 amRNSDirector/PDMR Shareholding
31st Jul 20189:27 amRNSForm 8.3 - [Carclo plc]
30th Jul 20181:49 pmRNSForm 8.3 - [Carclo plc]
30th Jul 201812:00 pmRNSForm 8.5 (EPT/RI) - Carclo Plc
30th Jul 201811:48 amRNSForm 8 (DD) - Carclo
27th Jul 20182:38 pmRNSForm 8.3 - [Carclo plc]

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.